• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Invesco Biotechnology & Genome ETF (NY:PBE)

    97.26 +0.03 (+0.03%)
    Official Closing Price Updated: 8:00 PM EDT, Sep 25, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 7,126
    Open 97.87
    Bid (Size) 96.07 (3,100)
    Ask (Size) 97.96 (3,100)
    Prev. Close 97.23
    Today's Range 96.47 - 97.87
    52wk Range 67.69 - 98.82
    Shares Outstanding 34,500
    Dividend Yield 3.34%
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    PBE vs. RSPH: Is a Biotech ETF or Equal-Weight Healthcare ETF the Better Choice for Investors? ↗
    PBE offers higher income and stronger returns, while RSPH provides broader diversification with lower costs and drawdown risk. 
    Via The Motley Fool
    Topics ETFs
    News headline image
    iShares' IYH or Invesco's PBE: Which Healthcare ETF Is the Better Long-Term Buy? ↗
    Broad diversification and lower costs favor iShares, but Invesco's concentrated biotech bet delivered 47% returns in one year—at the cost of steeper drawdowns. 
    Via The Motley Fool
    Topics ETFs

    Performance

    YTD
    +18.1%
    +18.1%
    1 Month
    -0.8%
    -0.8%
    3 Month
    +8.4%
    +8.4%
    6 Month
    +28.7%
    +28.7%
    1 Year
    +43.3%
    +43.3%

    More News

    Read More
    News headline image
    Pharma ETF or Biotech ETF: Which Matches Your Investing Mindset? ↗
    Via The Motley Fool
    Topics ETFs
    MannKind Stock Soared 8% Today: Why A Surge In Afrezza Inhaled Insulin Sales Matters ↗
    Via Stocktwits
    Akebia Therapeutics Stock Slumps After FDA Meeting Ends Without Path Forward for Vafseo Label Expansion ↗
    Via Stocktwits
    Ionis Pharma Stock Rises After Multiple Price Target Hikes On Heels Of Positive Study Results In Alexander Disease ↗
    Via Stocktwits
    News headline image
    IBBQ vs. PBE: Which Biotech ETF Is the Better Buy? ↗
    Via The Motley Fool
    Topics ETFs
    News headline image
    VanEck Pharmaceutical ETF vs. Invesco Biotech ETF: Which Fund Fits Your Investing Style? ↗
    Via The Motley Fool
    Topics ETFs
    News headline image
    XLV vs PBE: Is a Low-Cost Healthcare ETF the Better Buy Than a Focused Biotech Specialist? ↗
    Via The Motley Fool
    Topics ETFs
    News headline image
    VHT vs. PBE: Which Health Care ETF Is the Better Buy? ↗
    Via The Motley Fool
    Topics ETFs
    News headline image
    Why Did MNKD Stock Jump Over 7% In Pre-Market Today? ↗
    Via Stocktwits
    News headline image
    Pharma ETFs In A Tariff Storm: How Investors Can Hedge Risk ↗
    Via Benzinga
    Topics ETFs
    News headline image
    3 Biotech Stocks to Buy That Have CRISPR-Like Breakthrough Potential ↗
    Via InvestorPlace
    News headline image
    Mifepristone Abortion Pill Access in Limbo: Justice Department May Ask Supreme Court's Intervention ↗
    Via Benzinga
    News headline image
    Women's Reproductive Rights: US Court Preserves Access To Abortion Pill For Now, But With Tighter Rules ↗
    Via Benzinga
    News headline image
    New York and California Prepare For Potential Mifepristone Ban In Texas With Stockpiling Of Alternative Abortion Medications ↗
    Via Benzinga
    News headline image
    Attorney Generals of Over 20 States Sound Alarm Over Suspension Of Abortion Med Approval: "Devastating Risks" Ahead ↗
    Via Benzinga
    News headline image
    FDA Withdraws Lone Premature Birth Drug Makena Over Lack of Proven Benefits ↗
    Via Benzinga
    News headline image
    US Judge Weighs Nationwide Ban On Abortion Pills ↗
    Via Benzinga
    News headline image
    FDA Takes Action To Restrict Unlawful Import Of Animal Tranquilizer 'Tranq' Or ''Zombie Drug' ↗
    Via Benzinga
    News headline image
    7 Best Biotech Stocks to Buy in July 2022 ↗
    Via InvestorPlace
    News headline image
    Biotech ETFs That Outperformed Last Week ↗
    Via Talk Markets
    News headline image
    A Comprehensive Guide To Genomic ETFs ↗
    Via Talk Markets
    News headline image
    5 Top ETFs With Exposure To Biogen ↗
    Via Talk Markets
    News headline image
    5 Top ETFs With Exposure To Biogen ↗
    Via Benzinga

    Frequently Asked Questions

    Is Invesco Biotechnology & Genome ETF publicly traded?
    Yes, Invesco Biotechnology & Genome ETF is publicly traded.
    What exchange does Invesco Biotechnology & Genome ETF trade on?
    Invesco Biotechnology & Genome ETF trades on the New York Stock Exchange
    What is the ticker symbol for Invesco Biotechnology & Genome ETF?
    The ticker symbol for Invesco Biotechnology & Genome ETF is PBE on the New York Stock Exchange
    What is the current price of Invesco Biotechnology & Genome ETF?
    The current price of Invesco Biotechnology & Genome ETF is 97.26
    When was Invesco Biotechnology & Genome ETF last traded?
    The last trade of Invesco Biotechnology & Genome ETF was at 09/25/26 08:00 PM ET
    What is the market capitalization of Invesco Biotechnology & Genome ETF?
    The market capitalization of Invesco Biotechnology & Genome ETF is 3.36M
    How many shares of Invesco Biotechnology & Genome ETF are outstanding?
    Invesco Biotechnology & Genome ETF has 3M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.